NCCN 7th Annual Congress: Hematologic Malignancies™
The treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of new advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients.
This 2-day congress will focus on the most up-to-date treatment recommendations, important issues, controversies, recent scientific findings, and future directions for hematologic malignancies. The agenda includes presentations on myelodisplastic syndromes, multiple myeloma, chronic myelogenous leukemia, acute lymphoblastic leukemia, lymphomas, transplantation, and supportive care topics including management of anemia, treatment of venous thromboembolic disease, and management of idiopathic thrombocytopenic purpura.
This congress is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
- 11.25 Participation
- 9.90 Nurse
- 11.25 Pharmacist
- 11.25 Physician